ENTERO HEALTHCARE SOLUTIONS LIMITED ANNOUNCED ITS INITIAL PUBLIC OFFERING (IPO) TO OPEN ON FRIDAY, FEBRUARY 09, 2024 Sets Price Band fixed at ₹1195 per equity share to ₹1258 per Equity Share of face value of ₹10 each

Mumbai, 06th February 2024 (GNI): L-R: Gautam Kothari, Vice President, SBI Capital Market Ltd, Jayant Parekh, VP – General Counsel, Company Secretary & Compliance Officer, ENTERO HEALTHCARE SOLUTIONS LIMITED, C V Ram, Group Chief Financial Manager, ENTERO HEALTHCARE SOLUTIONS LIMITED, Prem Sethi, Promoter, Whole – Time Director & COO, ENTERO HEALTHCARE SOLUTIONS LIMITED, Prabhat Agarwal, Pramoter, Managing Director & CFO, ENTERO HEALTHCARE SOLUTIONS LIMITED, Sarun Agarwal, Vice President, Investment Banking, ICICI Securities Ltd, Ashutosh Prajapati, Director – Equity Capital Markets, JEFFERIES INDIA LIMITED, Rahul Choudhari, Vishal Desai, Senior Vice President, ECM DAM Capital Advisors Limited during the media conference to announce their IPO in Mumbai – All Photo by Sumant Gajinkar GNI

ENTERO HEALTHCARE SOLUTIONS LIMITED ANNOUNCED ITS INITIAL PUBLIC OFFERING (IPO) TO OPEN ON FRIDAY, FEBRUARY 09, 2024

• Price Band fixed at ₹1195 per equity share to ₹1258 per Equity Share of face value of ₹10 each of Entero Healthcare Solutions Limited (“Equity Shares”) 
• Anchor Investor Bidding Date : Thursday, February 08, 2024 
• Bid /Offer Opening Date : Friday, February 09, 2024 n

• Bid/ Offer Closing Date : Tuesday, February 13, 2024
• Bids can be made for a minimum of 11 Equity Shares and in multiples of 11 Equity Shares thereafter 

Mumbai, 06th February 2024 (GNI): Entero Healthcare Solutions Limited (the “Company”) proposes to open its initial public offering (IPO)(“Offer”) on Friday, February 09, 2024. Bid/ Offer Closing Date will be Tuesday, February 13, 2024. Anchor Investor Bidding Date is one Working Day prior to Bid/Offer Opening Date, that is, Thursday, February 08, 2024.  

The Price Band of the Offer has been fixed from ₹1195 per Equity Share to ₹1258 per Equity Share. Bids can be made for a minimum of 11 Equity Shares and in multiples of 11 Equity Shares thereafter.  

Mumbai, 06th February 2024 (GNI): L-R: Prem Sethi, Promoter, Whole – Time Director & COO, ENTERO HEALTHCARE SOLUTIONS LIMITED, Prabhat Agarwal, Pramoter, Managing Director & CFO, ENTERO HEALTHCARE SOLUTIONS LIMITED at the press conference to announce the IPO in Mumbai – photo by Sumant Gajinkar GNI

The Offer comprises of a fresh issue of equity shares aggregating up to ₹ 10,000 Million (The “Fresh Issue”) and an offer for sale of up to 47,69,475 Equity Shares (The “Offered Shares”), comprising of up to 470,210 equity shares by Prabhat Agrawal, up to 313,472 equity shares by Prem Sethi, up to 38,15,580  equity shares by Orbimed Asia Iii Mauritius Limited, up to 4,401 equity shares by Chethan M.P., up to 1,320 equity shares by Deepesh T. Gala, up to 8,802 equity shares by Hemant Jose Barros, up to 4,401 equity shares by Hemant Jaggi, up to 2,201 equity shares by K.R.V.S. Varaprasad, up to 39,610 equity shares by K.E. Prakash, up to 1,320 equity shares by Lavu Sahadev, up to 12,103 equity shares by Manoj K Sanghani, up to 8,802 equity shares by Millennium Medicare Private Limited, up to 2,201 equity shares by K. Naveen Kumar Gupta, up to 42,250 equity shares by Novacare Drug Specialities Private Limited, up to 15,074 equity shares by Petros Diamantides, up to 13,203 equity shares by Prashanth Ravindrakumar, up to 1,102 equity shares by Suraj Prakash Atreja, up to 1,320 equity shares by Venkata Ramana Siva Kumar Yanamadala and up to 12,103 equity shares by Vikramaditya Ambre (Collectively The “Selling Shareholders”) (The “Offer For Sale, and together with the fresh issue, The “Offer”). 

The Company intends to use the proceeds of the Fresh Issue utilize towards funding the repayment/prepayment, in full or part, of certain borrowings availed of by the Company, towards funding of long-term working capital requirements of the Company and its Subsidiaries during Fiscals 2025 and 2026, pursuing inorganic growth initiatives through acquisitions as well as for general corporate purposes.

The Equity Shares offered through this Red Herring Prospectus are proposed to be listed on BSE and NSE. The Company has received in-principle approvals from BSE and NSE for listing of the Equity Shares pursuant to their letters each dated November 8, 2023.

ICICI Securities Limited, Dam Capital Advisors Limited, Jefferies India Private Limited, JM Financial Limited and SBI Capital Markets Limited are the book running lead managers (“Book Running Lead Managers” or “BRLMs”) to the Offer.ends GNI